Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
Guidelines for Acromegaly Management: An UpdateШломо Мелмед, Philippe Chanson, Edward R. Laws et al.|The Journal of Clinical Endocrinology & Metabolism|2009Cited by 763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
A machine learning approach to predict early outcomes after pituitary adenoma surgeryTodd Hollon, Stephen E. Sullivan, Adish Parikh et al.|Neurosurgical FOCUS|2018Cited by 86